Skip to content
value.today
Alembic Limited logo

Alembic Limited

ALEMBICLTD.BO
$307 Mmarket cap on Nov 19, 2026+5.4% since Jan 2024
1D
-0.7%
Compare
World rank
#14,685
Revenue
$9 M
Mar-2021 ending year
value.today research
Net income
$2 M
17.8% margin
value.today research
Employees
—

Alembic Limited in brief

Alembic Limited is a listed company in the Pharmaceutical industry, based in India. It was founded in 1969. Its market value was $307 M on 19 November 2026, which makes it the 14,685th largest listed company in the world and the 1,085th largest in India on this site. In the year to Mar 2021 it had sales of $9 M and a net profit of $2 M, about 18 cents of profit for every dollar of sales.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Alembic Limited

Alembic Inc. is an American manufacturer of high-end electric basses, guitars and preamps. Founded in 1969, the company began manufacturing pre-amps before building complete instruments.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Alembic Limited timeline

2 events, 1969–1999
  1. 1969
  2. 🏁
    · approximate
    Founded by Rick Turner and Owsley Stanley
  3. 1999
  4. 📈
    Listed on National Stock Exchange of India as ALEMBICLTD
    First day of listing in the exchange's official list.

Events of Alembic Limited from Wikidata and the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Alembic Limited share price · NSE (ALEMBICLTD.NS)

daily · 2,473 trading days since 2016
Last close 111.48 INR (Nov 19, 2026)1 month: +17.2%1 year: +11.8%5 years: +5.8%10 years: +238.3%52-week range 70.46 – 118.23 INR
$0 M$44 M$89 M$133 M$177 M2017201820192020202120222023202420252026
DateOpenHighLowCloseChangeVolume
Nov 19, 2026111.90112.72110.61111.48-0.8%443,543
Nov 18, 2026113.78114.88112.00112.41-1.2%543,434
Nov 17, 2026114.94116.29113.21113.83-0.3%832,218
Nov 16, 2026113.82116.49111.92114.19+0.6%1.4 M
Nov 13, 2026112.50118.23112.50113.47-0.7%2.8 M
Nov 12, 2026116.00117.20113.00114.28-1.2%2.3 M
Nov 11, 2026106.41116.49105.52115.67+8.5%8.8 M
Nov 9, 202699.00114.3899.00106.58+5.3%30.2 M
Nov 6, 202696.70104.4095.10101.22+3.5%2.0 M
Nov 5, 202697.8099.4996.2197.82+3.3%868,666
Nov 4, 202688.6098.6588.5994.71+6.0%2.2 M
Nov 3, 202690.2391.4989.0089.35-0.5%205,688
Nov 2, 202687.2290.3887.0689.80+3.0%233,182
Oct 30, 202690.0090.0086.8187.22-2.3%267,280
Oct 29, 202687.0089.4986.8689.31+2.0%269,681
Oct 28, 202687.0087.9686.5887.59+0.4%230,721
Oct 27, 202685.5087.8884.4587.22+3.0%328,926
Oct 26, 202686.7386.9383.5084.69-2.4%695,879
Oct 23, 202690.7890.7886.0486.73-3.9%629,663
Oct 22, 202691.0093.2590.0090.28-1.9%483,801
Oct 21, 202695.5096.1091.5292.00-3.3%473,990
Oct 19, 202698.1599.1594.5895.16-2.3%283,606
Oct 16, 202695.9098.1695.6997.36+1.3%230,343
Oct 15, 202698.9898.9893.8096.13-2.6%446,712
Oct 14, 202698.0099.5097.5698.68+0.4%298,032
Oct 13, 2026100.22100.2296.1798.27-1.3%282,201
Oct 12, 2026100.14101.0098.3599.56+0.3%324,821
Oct 9, 2026100.50101.0098.8399.25-0.5%433,035
Oct 8, 2026103.39103.4899.0199.72-3.7%602,964
Oct 7, 2026105.00105.28102.81103.57—360,068

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Alembic Limited share price statistics

computed nightly from the daily prices
NSE · ALEMBICLTD.NSClose 111.48 INR (Nov 19, 2026)
1 day
-0.8%
1 week
-2.5%
1 month
+17.1%
3 months
+26.1%
Year to date
+10.2%
1 year
+11.8%
3 years
+36.6%
5 years
+5.8%
10 years
+229.8%
52-week low 70.46-5.7% from the highhigh 118.23
Highest on record 169.00 INR (Aug 23, 2024)Volume 2.0 M shares/dayValue traded 211.0 M INR/dayVolatility 46% (30d), 34% (1y)2,474 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$102 M$203 M$305 M$406 M2020202120222023202420252026

World rank over time

▲ up 706 places since 2020
2020-01-01: #15393#15,39320202021-01-01: #12660#12,66020212022-01-07: #15236#15,23620222022-12-25: #17479#17,47920222023-07-30: #16679#16,67920232024-01-05: #15956#15,95620242026-03-08: #8528#8,52820262026-11-12: #14557#14,55720262026-11-13: #14728#14,72820262026-11-16: #14652#14,65220262026-11-17: #14629#14,62920262026-11-18: #14674#14,67420262026-11-19: #14687#14,6872026

Rank in India: #546 (Jan 2020) · #476 (Jan 2021) · #685 (Jan 2022) · #791 (Dec 2022) · #816 (Jul 2023) · #845 (Jan 2024) · #780 (Mar 2026) · #1,084 (Nov 2026) · #1,087 (Nov 2026) · #1,075 (Nov 2026) · #1,080 (Nov 2026) · #1,081 (Nov 2026) · #1,085 (Nov 2026)

Key ratios

market cap and latest results
P/E ratio
181.6×
Price / sales
32.3×
Price / book
—
Free cash flow yield
—
Net margin
17.8%
Operating margin
—
Return on equity
—
Liabilities / assets
—

Annual results

Revenue
$9 M
Operating income
—
Net income
$2 M

Mar-2021 ending year

Mutual funds holding Alembic Limited#

17 funds hold shares worth $2 M. Since their previous reports 0 added shares and 2 sold, selling $0 M net.
Mutual funds holding Alembic Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP639,254$1 M—<0.01%−3.6%Jul 31, 2026
🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP360,019$0 M—<0.01%no changeJul 31, 2026
🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP269,593$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Global Ex-U.s. Real Estate Index FundThe Vanguard Group, Inc.263,179$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust146,783$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP101,475$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP69,654$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP61,733$0 M—<0.01%no changeJul 31, 2026
🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc.58,869$0 M—<0.01%no changeJun 30, 2026
🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP38,303$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP28,091$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP25,249$0 M—<0.01%no changeJul 31, 2026
🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP15,848$0 M—<0.01%no changeJul 31, 2026
🇺🇸 Avantis Emerging Markets Equity FundAmerican Century ETF Trust9,345$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust4,513$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust633$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP284$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 17 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Alembic Limited operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Alembic Limited: countries of operation
CountryPresenceRevenue there
🇮🇳 IndiaHeadquarters—
🇺🇸 USA1 office—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

How Alembic Limited compares in Pharmaceutical

  • Market cap$307 M · higher than 28% of 393
  • Revenue$9 M · higher than 7% of 324
  • Net margin17.8% · higher than 79% of 313
  • P/E ratio181.6× · lower than 4% of 172
  • Price / sales32.3× · lower than 1% of 219

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Alembic Limited🇮🇳$307 M181.6×17.8%—
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Annual results:
Mar-2021 ending year
Balance sheet:
Mar-2021 ending year
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research, Wikidata, Wikipedia.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Alembic Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Alembic Limited's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Alembic Limited? Suggest a correction